B9DW16 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiacgxefx4kezbyjux4mpcon5yzfqp4skbrptl5r4cyridjcoqbr2a/metadata.json
IPFS of structure file: 
bafybeigafwmh6onoqhhuqpjd77udfdnumj5vneocybgdayhkpzlwrdw7si/AF-B9DW16-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6296305fB33DA9137A8eE4a756D45467a3D1c9f6
First NFT owner address (bech32): 
genesis1v2trqhan8k53x75wujn4d4z5v73arj0kax2pfk
Current NFT ID #450443 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
450443
Accession (UniProt):
B9DW16
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Streptococcus uberis (strain ATCC BAA-854 / 0140J)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B9DW16 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B9DW16|SYL_STRU0 Leucine--tRNA ligase OS=Streptococcus uberis (strain ATCC BAA-854 / 0140J) OX=218495 GN=leuS PE=3 SV=1 MTFYNHKEIEPKWQDFWAKNHTFKTGTDSSKPKFYALDMFPYPSGAGLHVGHPEGYTATDILSRFKRAQGYNVLHPMGWDAFGLPAEQYAMDTGNDPADFTAENIANFKRQINSLGFSYDWDREVNTTDPNYYKWTQWIFTKLYEKGLAYEAEVPVNWVEELGTAIANEEVLPDGTSERGGYPVVRKPMRQWMLKITAYAERLLEDLEEVDWPESIKDMQRNWIGKSVGANITFNVKDSEESFTVFTTRPDTLFGATYAVLAPEHALVDAITTEEQAEAIAEYKRQASLKSDLARTDLAKEKTGVWTGAYAINPVNGKEMPIWIADYVLSSYGTGAIMAVPAHDERDWEFAKQFHLDIIPVLEGGNVQEAAYTEDGLHINSDFLDGLNKEEAIAKTVAWLEEKEVGNEKVSYRLRDWLFSRQRYWGEPIPIIHWEDGTSTAVPEDQLPLILPVTKDIHPSGTGESPLANITDWLEVTREDGVKGRRETNTMPQWAGSSWYYLRYIDPKNDKAIADPDLLKQWLPVDIYVGGAEHAVLHLLYARFWHKVLYDLGVVPTKEPFQKLFNQGMILGTSYRDHRGALVATDKVEKREGSYFHIETGEELEQAPAKMSKSLKNVVNPDDVVEQYGADTLRVYEMFMGPLDASIAWSEEGLEGSRKFLDRVYRLITTKEMTGDNSGALDKVYHETVKAVTEQIESMKFNTAIAQLMIFVNAANKEDKLYKEQAKGFVQLIAPFAPHLGEELWQVLTDSNQSISHVAWPTWDENKLVENDVEIVVQIKGKVKAKLVLAKDLSKEELEAAALSHEKIQAEIAGKEIVKVIAVPNKLVNIVVK